252 related articles for article (PubMed ID: 17244894)
1. Antagonistic effects of bone morphogenetic protein-4 and -7 on renal mesangial cell proliferation induced by aldosterone through MAPK activation.
Otani H; Otsuka F; Inagaki K; Takeda M; Miyoshi T; Suzuki J; Mukai T; Ogura T; Makino H
Am J Physiol Renal Physiol; 2007 May; 292(5):F1513-25. PubMed ID: 17244894
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of aldosterone-induced catecholamine production by bone morphogenetic protein-4 through activating Rho and SAPK/JNK pathway in adrenomedullar cells.
Goto J; Otsuka F; Yamashita M; Suzuki J; Otani H; Takahashi H; Miyoshi T; Mimura Y; Ogura T; Makino H
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E904-16. PubMed ID: 19190257
[TBL] [Abstract][Full Text] [Related]
4. Activation of c-Jun NH(2)-terminal kinase 1 increases cellular responsiveness to BMP-2 and decreases binding of inhibitory Smad6 to the type 1 BMP receptor.
Liu H; Liu Y; Viggeswarapu M; Zheng Z; Titus L; Boden SD
J Bone Miner Res; 2011 May; 26(5):1122-32. PubMed ID: 21542012
[TBL] [Abstract][Full Text] [Related]
5. Enhanced expression of bone morphogenetic protein system in aldosterone-treated mouse kidneys.
Suzuki J; Otsuka F; Matsumoto Y; Inagaki K; Miyoshi T; Takeda M; Tsukamoto N; Nakamura E; Ogura K; Makino H
Hypertens Res; 2012 Mar; 35(3):312-7. PubMed ID: 22072104
[TBL] [Abstract][Full Text] [Related]
6. Novel action of activin and bone morphogenetic protein in regulating aldosterone production by human adrenocortical cells.
Suzuki J; Otsuka F; Inagaki K; Takeda M; Ogura T; Makino H
Endocrinology; 2004 Feb; 145(2):639-49. PubMed ID: 14592955
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein activities are enhanced by 3',5'-cyclic adenosine monophosphate through suppression of Smad6 expression in osteoprogenitor cells.
Sugama R; Koike T; Imai Y; Nomura-Furuwatari C; Takaoka K
Bone; 2006 Feb; 38(2):206-14. PubMed ID: 16203197
[TBL] [Abstract][Full Text] [Related]
8. Involvement of bone morphogenetic protein-6 in differential regulation of aldosterone production by angiotensin II and potassium in human adrenocortical cells.
Inagaki K; Otsuka F; Suzuki J; Kano Y; Takeda M; Miyoshi T; Otani H; Mimura Y; Ogura T; Makino H
Endocrinology; 2006 Jun; 147(6):2681-9. PubMed ID: 16527843
[TBL] [Abstract][Full Text] [Related]
9. Functional relationship between fibroblast growth factor-8 and bone morphogenetic proteins in regulating steroidogenesis by rat granulosa cells.
Miyoshi T; Otsuka F; Yamashita M; Inagaki K; Nakamura E; Tsukamoto N; Takeda M; Suzuki J; Makino H
Mol Cell Endocrinol; 2010 Aug; 325(1-2):84-92. PubMed ID: 20434519
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells.
Xiao G; Gopalakrishnan R; Jiang D; Reith E; Benson MD; Franceschi RT
J Bone Miner Res; 2002 Jan; 17(1):101-10. PubMed ID: 11771655
[TBL] [Abstract][Full Text] [Related]
11. Regulation of MAP kinase by the BMP-4/TAK1 pathway in Xenopus ectoderm.
Goswami M; Uzgare AR; Sater AK
Dev Biol; 2001 Aug; 236(2):259-70. PubMed ID: 11476570
[TBL] [Abstract][Full Text] [Related]
12. Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells.
Mazak I; Fiebeler A; Muller DN; Park JK; Shagdarsuren E; Lindschau C; Dechend R; Viedt C; Pilz B; Haller H; Luft FC
Circulation; 2004 Jun; 109(22):2792-800. PubMed ID: 15159288
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-beta1.
Naito T; Masaki T; Nikolic-Paterson DJ; Tanji C; Yorioka N; Kohno N
Am J Physiol Renal Physiol; 2004 Feb; 286(2):F278-87. PubMed ID: 14583433
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effects of Nell-1 and BMP-2 on the osteogenic differentiation of myoblasts.
Cowan CM; Jiang X; Hsu T; Soo C; Zhang B; Wang JZ; Kuroda S; Wu B; Zhang Z; Zhang X; Ting K
J Bone Miner Res; 2007 Jun; 22(6):918-30. PubMed ID: 17352654
[TBL] [Abstract][Full Text] [Related]
16. Mutual regulation of follicle-stimulating hormone signaling and bone morphogenetic protein system in human granulosa cells.
Miyoshi T; Otsuka F; Suzuki J; Takeda M; Inagaki K; Kano Y; Otani H; Mimura Y; Ogura T; Makino H
Biol Reprod; 2006 Jun; 74(6):1073-82. PubMed ID: 16436528
[TBL] [Abstract][Full Text] [Related]
17. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 mitogen-activated protein kinase activation.
Takahashi M; Otsuka F; Miyoshi T; Otani H; Goto J; Yamashita M; Ogura T; Makino H; Doihara H
J Endocrinol; 2008 Dec; 199(3):445-55. PubMed ID: 18780779
[TBL] [Abstract][Full Text] [Related]
19. Astragaloside II induces osteogenic activities of osteoblasts through the bone morphogenetic protein-2/MAPK and Smad1/5/8 pathways.
Kong XH; Niu YB; Song XM; Zhao DD; Wang J; Wu XL; Zhang R; Mei QB
Int J Mol Med; 2012 Jun; 29(6):1090-8. PubMed ID: 22426655
[TBL] [Abstract][Full Text] [Related]
20. Effects of bone morphogenetic protein (BMP) on adrenocorticotropin production by pituitary corticotrope cells: involvement of up-regulation of BMP receptor signaling by somatostatin analogs.
Tsukamoto N; Otsuka F; Miyoshi T; Yamanaka R; Inagaki K; Yamashita M; Otani H; Takeda M; Suzuki J; Ogura T; Iwasaki Y; Makino H
Endocrinology; 2010 Mar; 151(3):1129-41. PubMed ID: 20056821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
